PubRank

Natalia A Loktionova

Author PubWeight™ 13.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene. J Clin Invest 2009 1.17
2 Characterization of a mutagenic DNA adduct formed from 1,2-dibromoethane by O6-alkylguanine-DNA alkyltransferase. J Biol Chem 2003 1.10
3 Activation of bis-electrophiles to mutagenic conjugates by human O6-alkylguanine-DNA alkyltransferase. Chem Res Toxicol 2004 1.10
4 2-amino-O4-benzylpteridine derivatives: potent inactivators of O6-alkylguanine-DNA alkyltransferase. J Med Chem 2004 1.09
5 Human variants of O6-alkylguanine-DNA alkyltransferase. DNA Repair (Amst) 2007 0.97
6 O6-pyridyloxobutylguanine adducts contribute to the mutagenic properties of pyridyloxobutylating agents. Chem Res Toxicol 2005 0.92
7 Alkyltransferase-mediated toxicity of 1,3-butadiene diepoxide. Chem Res Toxicol 2008 0.87
8 Nuclear-localizing O6-benzylguanine-resistant GFP-MGMT fusion protein as a novel in vivo selection marker. Exp Hematol 2004 0.84
9 Differential inactivation of polymorphic variants of human O6-alkylguanine-DNA alkyltransferase. Biochem Pharmacol 2007 0.83
10 Inactivation of O(6)-alkylguanine-DNA alkyltransferase by folate esters of O(6)-benzyl-2'-deoxyguanosine and of O(6)-[4-(hydroxymethyl)benzyl]guanine. J Med Chem 2007 0.82
11 Beta-glucuronidase-cleavable prodrugs of O6-benzylguanine and O6-benzyl-2'-deoxyguanosine. J Med Chem 2005 0.82
12 Substitution of aminomethyl at the meta-position enhances the inactivation of O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine. J Med Chem 2008 0.80
13 Degradation of BRCA2 in alkyltransferase-mediated DNA repair and its clinical implications. Cancer Res 2008 0.79
14 Effect of O6-alkylguanine-DNA alkyltransferase on genotoxicity of epihalohydrins. Environ Mol Mutagen 2009 0.78
15 Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model. Cancer Chemother Pharmacol 2010 0.75